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Abstract
Objective: There is conflicting evidence about resting carbon dioxide levels in asthmatic individuals. We wanted to
determine if transcutaneously measured carbon dioxide levels prior and during bronchial provocation testing differ
according to asthma status reflecting dysfunctional breathing.
Methods: We investigated active firefighters and policemen by means of a validated questionnaire on respiratory
symptoms, spirometry, bronchial challenge testing with methacholine (MCT) and measurement of transcutaneous blood
carbon dioxide partial pressure (PtcCO2) at rest prior performing spirometry, one minute and five minutes after termination
of MCT. A respiratory physician blinded to the PtcCO2 results assigned a diagnosis of asthma after reviewing the available
study data and the files of the workers medical screening program.
Results: The study sample consisted of 128 male and 10 female individuals. Fifteen individuals (11%) had physician-
diagnosed asthma. There was no clinically important difference in median PtcCO2 at rest, one and five minutes after
recovery from MCT in asthmatics compared to non-asthmatics (35.6 vs 35.7 mmHg, p=0.466; 34.7 vs 33.4 mmHg, p=0.245
and 37.4 vs 36.4 mmHg, p=0.732). The median drop in PtcCO2 during MCT and the increase after MCT was lower in
asthmatics compared to non-asthmatics (0.1 vs 3.2 mmHg, p=0.014 and 1.9 vs 2.9 mmHg, p=0.025).
Conclusions: PtcCO2 levels at rest prior and during recovery after MCT do not differ in individuals with or without physician
diagnosed asthma. The fall and subsequent increase in PtcCO2 levels are higher in non-asthmatics than in asthmatics and
seems to be related with increased number of respiratory maneuvers during MCT.
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Introduction
Asthma is associated with a chronic inflammation of the airways
associated with symptoms such as cough, wheezing, sputum
production and chest tightness. Further several studies have shown
an association between asthma and higher anxiety sensitivity
scores and panic disorder [1,2,3].
Breathing abnormalities such as an abnormal breathing pattern,
unsteadiness of breathing in response to exercise or voluntary
hyperventilation, increased respiratory rate, a predominantly
intercostal respiratory effort as well as frequent sighing have been
classified as dysfunctional breathing [4]. Thomas and co-workers
have shown that dysfunctional breathing can be found in a third of
asthmatic woman and a fifth of asthmatic men seen in general
practice and in about 8% of the general population when
evaluated with a questionnaire to detect functional breathing
problems, the Nijmwegen Questionnaire [4,5]. The assumption
that dysfunctional breathing might be associated with lower
end-tidal carbon dioxide partial pressures (PETCO2) has led to the
idea to offer asthmatics breathing retraining to raise PETCO2 [6].
It was shown in an experimental setting that increasing PETCO2
can decrease respiratory resistance while decreasing PETCO2
in turn led to an increase in resistance and decrease in airway
reactance in asthmatic individuals [7]. Currently, there is
conflicting data about resting and post bronchial challenge testing
PETCO2 and their association with asthma status. Therefore we
wanted to determine prospectively, if resting transcutaneous blood
carbon dioxide partial pressures (PtCO2) prior and after bronchial
challenge testing or the change in PtcCO2 were different in
individuals with or without asthma.
Materials and Methods
The study was approved by the local ethics committee EKBB
(Ethikkommission beider Basel) and all participants gave written
informed consent.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32464In the context of a study in active firefighters and policemen in
Switzerland to measure asthma prevalence, workers answered a
validated questionnaire on respiratory symptoms. The population
studied was a convenience sample of workers recruited among the
current firefighting and police workforce in the city of Basel.
Subsequently, they underwent bronchoprovocation testing with
methacholine (MCT) according to a widely applied standardized
protocol, that has been used by the European Community
Respiratory Health Survey (ECRHS) [8]. The study protocol
included a defined sequence of inhalations with a maximum
cumulative dose of 2 mg methacholine and spirometry maneuvers
(Figure 1). The test was considered positive when an individual
FEV1 fell by 20% or greater during MCT. We allowed
spontaneous recovery of lung function in all individuals for five
minutes after all inhalation steps were performed or the test was
considered positive before a short acting bronchodilatator was
eventually administered.
During the metacholine challenge, PtcCO2 was measured by
using a validated, combined ear sensor for pulse oximetry and
PtcCO2 (SenTec AG, Therwil, Switzerland), permitting to collect
data non-invasively and corresponding to ABG analysis [9]. The
response time of the sensor regarding measurement of PtcCO2 was
shown to be less than one minute [10]. The change of the sensor
membrane, the device calibration and sensor application was done
as required by the manufacturer. Patients were seated and the
sensor was taken out of the docking station immediately before the
measurement was started. We recorded PtcCO2 of all subjects at
rest prior (PRE), one and five minutes after (1MIN and 5MIN)
finishing MCT. Recording of PtcCO2 was always performed prior
to performing spirometry. For the first reading (PRE) we followed
the manufacturer’s recommendation to wait until the ‘‘PCO2
stabilizing’’ message disappeared from the monitor.
Sensitivity analysis was performed by assigning individuals a
diagnosis of asthma, according to two widely used definitions:
Having a) physician-diagnosed asthma or b) had wheezing in the last
twelve months plus a positive result in the MCH test (Wheeze/
MCHPD20+) [11]). A respiratory physician blinded to the PtcCO2
results obtained assigned a diagnosis of asthma (physician-diagnosed
asthma), after reviewing the available data (questionnaire, lung
function, methacholine and exhaled nitric oxide test results,
medication use and files of workers the medical screening
program). For comparison we also present the data of those
individuals in which the MCT was considered positive, when a
drop in FEV1 of 20% or greater occurred during the test
(MCHPD20+).
Continuous variables were expressed as median and inter-
quartile range. Non-parametric tests were performed for paired
and unpaired measures as most of the data was not normally
distributed. Statistic tests were performed using SPSS-software
(version 19, IBM Corporation, Somers, New York, USA).
Results
We investigated 128 male and 10 female individuals with a
mean age of 40 years (range 22–63 years). Twenty-four individuals
(17%) had a positive MCT (MCHPD20+), 15 (11%) had physician-
diagnosed asthma, and 12 (9%) had wheeze in the last 12 months and
had a positive MCT (Wheeze/MCHPD20+).
Median PtcCO2 values regardless of asthma status measured
prior and during MCT can be seen in Table 1. The median
PtcCO2 decrease during MCT (PRE-1MIN) was 3.0 mmHg (IQR
4.7 mmHg) whereas the median increase during recovery phase
after MCT (1MIN-5MIN) was 2.7 mmHg (IQR 3.4). Median
PtcCO2 five minutes after the end of MCT, was not clinically or
statistically significantly different from pre-test values (PRE-5MIN,
p=0.108).
Figure 1. Sequence of PtcCO2 measurements, inhalation maneuvers and spirometry. PRE=transcutaneous blood carbon dioxide partial
pressures (PtcCO2) prior to methacholine bronchial challenge test (MCT), 1MIN=PtcCO2 one minute after termination of MCT, 5MIN=PtcCO2 five
minutes after termination of MCT.
doi:10.1371/journal.pone.0032464.g001
Table 1. Median values of transcutaneous carbon dioxide
partial pressures (PtcCO2) during the course of bronchial
challenge testing with methacholine.
n PtcCO2 (mmHg) PtcCO2 (mmHg) p-value
PRE-1MIN 138 PRE 35.6 (5.5) 1MIN 33.5 (5.7) ,0.001
PRE-5MIN 138 PRE 35.6 (5.5) 5MIN 36.4 (5.0) 0.108
1MIN–5MIN 138 1MIN 33.5 (5.7) 5MIN 36.4 (5.0) ,0.001
Data is expressed as median (interquartile range). PtcCO2=transcutaneous
blood carbon dioxide partial pressure. PRE=PtcCO2 prior to methacholine
bronchial challenge, 1MIN=PtcCO2 one minute after termination of
methacholine bronchial challenge, 5MIN=PtcCO2 five minutes after
termination of methacholine bronchial challenge.
doi:10.1371/journal.pone.0032464.t001
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no significant differences in median PtcCO2, prior, during and
after recovery from MCT between the asthmatic and non-
asthmatic individuals for all three definitions (Table 2). However
when comparing the median change in individuals PtcCO2 during
MCT those classified as having asthma had lower fall than those
without asthma, accordingly during recovery phase after the test
the increase in PtcCO2 was higher in non-asthmatics compared to
asthmatics (Table 3).
Discussion
There was no clinically or statistically important difference in
median PtcCO2 in individuals with asthma at rest, immediately
after and after recovery from MCT. However the change in
PtcCO2 during the MCT was more pronounced in individuals
without asthma, most likely because they performed more forced
in- and expiratory maneuvers during MCT resulting in more
iatrogenic induced hyperventilation.
Firefighters and policemen are exposed to various airway
irritants during work and have been shown to have a high
prevalence of respiratory symptoms and asthma [12,13]. There-
fore the study was conducted to measure and compare the
prevalence of respiratory symptoms, bronchial hyperresponsive-
ness and asthma in these populations. While it was possible to
measure over 90% of the active professional firefighters in the city
of Basel, we had to randomly select a convenience sample of 60
out of about 600 policemen in the active workforce of the city.
In our study population we did not find clinically nor statistically
significant difference in resting and post MCT PtcCO2 levels
according to asthma status. This finding is in discordance with
several studies that have reported resting PETCO2 levels to be
lower in asthmatic individuals [7,14,15]. One must be cautious
when comparing these findings with our results. While the patients
in aforementioned studies were recruited among a hospital
population, we have identified asthmatics in a population sample
of apparent healthy workers. Dysfunctional breathing has been
reported to induce respiratory symptoms [16] and this may lead
asthmatics to seek medical treatment. Thus, the prevalence of
dysfunctional breathing can be expected to be lower in asthmatics
identified during studies at the workplace or in population studies.
Forced inspiratory and expiratory maneuvers during MCT will
reduce rest carbon dioxide levels in the blood [16]. The device we
used to measure PtcCO2 has been validated and was shown to
correlate well with invasive determination of blood CO2 levels [9].
Further this device has successfully been used to diagnose
hyperventilation syndrome in individual patients in the clinic
[17]. Performing MCT has been shown to induce transient
hypoxemia post testing as well as to induce ventilation/perfusion
mismatch [18,19]. In our study we could see a more pronounced
drop in PtcCO2 in individuals who had a negative MCT and were
not diagnosed with asthma. Healthy individuals with light or no
bronchial hyperresponsiveness to methacholine need to perform
more inhalation maneuvers to inhale increasing methacholine
doses during the MCT. As spirometry is performed after each dose
step, the number of spirometries increases accordingly. Koulouris
and coworkers suggested that performing bronchial challenge
testing in asthmatics may lead to an increase of dead space [20]
which would lead to less CO2 elimination. However as a group the
median PtcCO2 levels were not clinically or statistically different
according to asthma status one minute and five minutes after
termination of MCH when spontaneous recovery was allowed.
Dysfunctional breathing might be a temporal rather than a
continuous phenomenon and thus the measurements and
bronchial challenge test we performed at a single occasion were
unable to detect hypocapnia as a result of dysfunctional breathing
Table 2. Comparison of median transcutaneous carbon
dioxide partial pressures (PtcCO2) according to asthma
definition during the course of bronchial challenge testing
with methacholine.
PtcCO2(mmHg)
Asthma
definition n PRE 1 Min 5 Min
Physician-
diagnosed
Present 15 35.6 (4.5)
a 34.7 (6.5)
a 37.4 (5.4)
a
Not
present
123 35.7 (5.5) 33.4 (5.9) 36.4 (4.9)
Wheeze/MCHPD20 Present 12 36.3 (6.0)
a 35.1 (5.6)
a 37.5 (5.0)
a
Not
present
126 35.6 (5.5) 33.4 (5.9) 36.4 (5.0)
MCHPD20 Present 24 35.7 (5.3)
a 34.9 (6.1)
b 37.2 (4.2)
a
Not
present
114 35.6 (5.6) 33.2 (5.8) 36.4 (5.2)
Data is expressed as median (interquartile range). PtcCO2=transcutaneous
blood carbon dioxide partial pressures. PRE=PtcCO2 prior to methacholine
bronchial challenge, 1MIN=PtcCO2 one minute after termination of
methacholine bronchial challenge, 5MIN=PtcCO2 five minutes after
termination of methacholine bronchial challenge. MCHPD20=Fall in FEV1
$20% during bronchial challenge testing with methacholine.
a=Not significant with p.0.1,
b=Not significant with p,0.1.
doi:10.1371/journal.pone.0032464.t002
Table 3. Comparison of median values of change of
transcutaneous carbon dioxide partial pressures (PtcCO2)
according to asthma definition during testing and during
recovery after methacholine provocation testing.
D PtcCO2(mmHg)
Asthma
definition n PRE-1MIN PRE-5MIN 1MIN–5MIN
Physician-
diagnosed
Present 15 0.1 (4.3)* 21.4 (3.4)
a 21.9 (1.9)*
Not
present
123 3.2 (5.0) 2.6 (4.0) 22.9 (3.6)
Wheeze/MCHPD20 Present 12 0.6 (4.0)* 21.2 (3.1)
a 21.8 (3.0)
b
Not
present
126 3.2 (4.8) 20.7 (3.9) 22.8 (3.5)
MCHPD20 Present 24 1.0 (4.2)* 21.0 (3.3)
a 21.8 (2.9)*
Not
present
114 3.2 (5.2) 20.7 (4.0) 22.9 (3.5)
Data is expressed as median (interquartile range). PtcCO2=transcutaneous
blood carbon dioxide partial pressures. PRE=PtcCO2 prior to methacholine
bronchial challenge, 1MIN=PtcCO2 one minute after termination of
methacholine bronchial challenge, 5MIN=PtcCO2 five minutes after
termination of methacholine bronchial challenge. MCHPD20=Fall in FEV1
$20% during bronchial challenge testing with methacholine.
a=Not significant with p.0.1,
b=Not significant with p,0.1,
*=Significant with p#0.05.
doi:10.1371/journal.pone.0032464.t003
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data regarding the intra-individual variability of PETCO2 or
PtcCO2 in asthmatics. Using the Nijmegen questionnaire to
determine hyperventilation-associated complaints would have
allowed us to correlate these findings with PtcCO2 at rest and
during bronchial challenge testing. However there has been
criticism that the Nijmwegen questionnaire is not a valid tool for
identification of hyperventilation in asthmatics because of the co-
occurrence of asthma and anxiety - in which the symptoms might
be similar – and due to the fact that this questionnaire was
validated only in a non-asthmatic population [21,22].
A spontaneous fall in PETCO2 of at least 0.25% during the
adaptation period before a hyperventilation provocation test was
shown to have an accuracy of 70% for the diagnosis of
hyperventilation syndrome, while the responses of PETCO2
during provocation test were reported not to be useful for the
diagnosis of hyperventilation syndrome [23]. Another reason for
lack of difference in resting and post MCH levels might be the fact
that our sample consisted of mainly male participants. In
Switzerland, firefighting and less so policing is still a male
dominated area. As shown in asthmatics and non-asthmatics
dysfunctional breathing seems to be more common in female than
in males [5] and this increases the risk of a type II error due to
insufficient power.
Conclusions
In a group of workers undergoing bronchial challenge testing to
diagnose asthma we could not find an association of low resting
PtcCO2 levels with asthma status reflecting chronic hyperventila-
tion or dysfunctional breathing. Median PtcCO2 levels and change
in PtcCO2 levels during bronchial challenge testing with
methacholine is dependent on the number of respiratory
maneuvers during the test. PtcCO2 levels during recovery or five
minutes after bronchial challenge testing do not help to identify
individuals with or without asthma. Further studies are needed to
determine the association of individual resting PtcCO2 levels with
dysfunctional breathing and if the breathing pattern and thus
PtcCO2 levels are different regarding the presence of dysfunctional
breathing during experimental nonspecific bronchial challenge.
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